Nieves Martinez Lago/LinkedIn
Aug 22, 2025, 11:54
Nieves Martinez Lago: KEYNOTE-585 Final Analysis
Nieves Martinez Lago, Specialist in the Field (FEA) of Medical Oncology at University Hospital Complex of Santiago de Compostela, shared a post on X:
“KEYNOTE-585 Final Analysis
http://ascopubs.org/doi/abs/10.120…
Resectable GC/GEJ (~1000 pts)
Pembro+CT vs placebo+CT
Main: OS 71.8 vs 55.7 mo (HR 0.86), EFS HR 0.81
FLOT: OS NR vs 55.7 mo (HR 0.86), EFS HR 0.80
↑pathCR | G≥3 AEs similar | QoL preserved
Why MATTERHORN positive but KEYNOTE-585 not?”
More posts featuring Nieves Martinez Lago.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 22, 2025, 11:54
Aug 22, 2025, 11:44
Aug 22, 2025, 11:36
Aug 22, 2025, 11:25
Aug 22, 2025, 11:06
Aug 22, 2025, 10:50
Aug 22, 2025, 10:42